Decade-Long Study: Omnitrope’s Impact on Bone Age in American Males with GHD
Reading Time: 2 minutesIntroduction Omnitrope, a recombinant human growth hormone (rhGH), has been extensively used in pediatric endocrinology to address growth disorders. Its impact on bone age advancement, a critical parameter in assessing growth and development, remains a focal point of clinical interest. This article delves into a decade-long prospective study examining the effects of Omnitrope on bone age advancement in American males,... Read more »

